Elevance Health (ELV)

NYSE Market Closed

Elevance Health, Inc. is one of the largest managed healthcare companies in the United States, serving tens of millions of medical members through a mix of employer-sponsored, individual, Medicaid, and Medicare-related plans. The company is best known for its health benefits business, but it also operates a growing services platform that includes pharmacy benefit management, care delivery, analytics, and other healthcare support functions.

A defining feature of Elevance Health is its position within the Blue Cross Blue Shield system. The company is the licensed Blue Cross Blue Shield operator in 14 states, making it the largest single provider of BCBS-branded coverage in the country. That brand presence gives Elevance a strong position in many local insurance markets, particularly among employers and government-sponsored programmes.

Elevance has expanded beyond its traditional commercial insurance base through acquisitions and investment in public-sector healthcare. The 2012 purchase of Amerigroup strengthened its Medicaid capabilities, while later deals, including MMM in Puerto Rico, broadened its Medicare Advantage and government-programme reach. These businesses expose the company to long-term demand from ageing populations and public healthcare funding, while also requiring close management of regulation, reimbursement, and medical cost trends.

The company’s Carelon segment reflects Elevance’s shift toward a more integrated healthcare model. Through pharmacy services, behavioural health, payment integrity, and care management capabilities, Elevance seeks to capture more of the healthcare value chain and improve outcomes for members. For investors, ELV represents a major US health insurer with scale, a distinctive Blue Cross Blue Shield footprint, and increasing exposure to healthcare services beyond traditional insurance underwriting.

415.53 USD
413.00 USD
+6.09 (+1.49%)
Pre-market

Last updated

Market Cap
90.24B
P/E
17.21
P/FCF
13.99
P/S
0.45
Enterprise Value
112.42B
Sector
Financials
Industry
Hospital and Medical Service Plans
Address
220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
GlobeNewswire Inc.

ELV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Elevance Health, Inc.

23 Apr 2026, 01:00 AM
GlobeNewswire Inc.

Elevance Health, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

03 Mar 2026, 00:41 AM
Investing.com

3 Beaten-Down Stocks Ready to Kick Off 2026 on the Front Foot

02 Jan 2026, 18:32 PM
Investing.com

Elevance Health: Solid Q3 Results Support Confident Full-Year Guidance

21 Oct 2025, 12:23 PM
GlobeNewswire Inc.

Important Notice to Long-Term Shareholders of Elevance Health, Inc. (NYSE: ELV); Humana Inc. (NYSE: HUM); Maison Solutions Inc. (NASDAQ: MSS); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

04 Oct 2025, 15:27 PM
GlobeNewswire Inc.

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Elevance Health Inc. (NYSE: ELV); Fluor Corporation (NYSE: FLR); and Fly-E Group, Inc. (NASDAQ: FLYE): Grabar Law Office is Investigating Claims on Your Behalf

23 Sept 2025, 17:53 PM
GlobeNewswire Inc.

Top Technology Executives Recognized at the 2025 Carolina CIO ORBIE Awards

19 Sept 2025, 18:40 PM
Investing.com

Elevance Stock Faces Headwinds After Q2 EPS Miss and Margin Compression

17 Jul 2025, 22:03 PM
GlobeNewswire Inc.

ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

16 Jul 2025, 01:02 AM
Investing.com

Why Centene Stock Dropped 40% — And Whether It's a Buy Now

08 Jul 2025, 14:24 PM
GlobeNewswire Inc.

ELV DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV

05 Jul 2025, 18:44 PM
GlobeNewswire Inc.

Elevance Health (NYSE: ELV) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

03 Jul 2025, 19:41 PM
GlobeNewswire Inc.

ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

29 Jun 2025, 21:00 PM
GlobeNewswire Inc.

ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

28 Jun 2025, 13:40 PM
GlobeNewswire Inc.

ELV INVESTOR DEADLINE: Elevance Health, Inc. Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 11 Court Deadline (NYSE:ELV)

28 Jun 2025, 12:46 PM
GlobeNewswire Inc.

ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

24 Jun 2025, 21:00 PM
GlobeNewswire Inc.

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE

22 Jun 2025, 19:16 PM
GlobeNewswire Inc.

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

22 Jun 2025, 17:14 PM
GlobeNewswire Inc.

ELV FRAUD ALERT: Elevance Health, Inc. Investors are Reminded of Ongoing Securities Fraud Class Action -- Contact BFA Law by July 11 Legal Deadline (NYSE:ELV)

22 Jun 2025, 14:33 PM
GlobeNewswire Inc.

ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

17 Jun 2025, 21:00 PM
Market Cap
90.24B
Enterprise Value
112.42B
P/E
17.21
P/B
2.06
P/S
0.45
EV / EBITDA
12.27
EV / Sales
0.56
EPS
24.14
Dividend Yield
1.68%
P/FCF
13.99
P/CF
11.87
Free Cash Flow
6.45B
ROE
11.94%
ROA
4.17%
Debt / Equity
0.73
Current Ratio
4.07
Quick Ratio
4.07
Cash
1.21
Avg Volume
1.7M
Fundamentals Snapshot Price
415.53

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 50.18B 49.75B 50.71B 49.78B 48.89B
Gross profit 14.57B 11.68B 12.57B 13.07B 13.58B
Operating income 2.66B 581M 1.76B 2.63B 3.14B
EBITDA 3.02B 987M 2.14B 3.01B 3.51B
Net income 1.76B 547M 1.19B 1.74B 2.18B
Basic EPS 8.03 2.55 5.32 7.72 9.64
Diluted EPS 8 2.54 5.32 7.72 9.61

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 125.83B 121.49B 122.75B 121.94B 119.72B
Total liabilities 81.79B 77.47B 78.67B 78.09B 77.1B
Total equity 44.04B 44.03B 44.08B 43.85B 42.62B
Cash & equivalents 9.66B 9.49B 8.71B 8.56B 7.5B
Current assets 32.45B 31.03B 31.06B 31.69B 29.68B
Current liabilities 7.97B 8.82B 7.92B 8.84B 8.77B

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 4.33B 84M 1.14B 2.05B 1.02B
Investing cash flow -1.64B 464M -1.22B -687M 103M
Financing cash flow -2.52B 236M 243M -308M -1.91B
Change in cash 166M 778M 153M 1.06B -788M
Kind Filing Date Link
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 144 — Elevance Health, Inc. View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — Penczek Ronald W View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 8-K — Elevance Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — HAY LEWIS III View Filing
form 4 Form 4 — COLLIS STEVEN H View Filing
form 4 Form 4 — PERU RAMIRO G View Filing
form 4 Form 4 — Schneider Ryan M. View Filing
form 4 Form 4 — SCHULMAN AMY W View Filing
form 4 Form 4 — Dixon Robert L JR View Filing
form 4 Form 4 — DeVore Susan D. View Filing
form 4 Form 4 — STRABLE-SOETHOUT DEANNA D View Filing
form 4 Form 4 — Neri Antonio F View Filing
form 4 Form 4 — Jallal Bahija View Filing
edgar index SCHEDULE 13G — Elevance Health, Inc. View Filing
edgar index 8-K — Elevance Health, Inc. View Filing
edgar index 10-Q — Elevance Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index PX14A6G — Elevance Health, Inc. View Filing
edgar index DEF 14A — Elevance Health, Inc. View Filing
edgar index DEFA14A — Elevance Health, Inc. View Filing
edgar index SCHEDULE 13G/A — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
form 4 Form 4 — SCHULMAN AMY W View Filing
edgar index 8-K — Elevance Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 144 — Elevance Health, Inc. View Filing
form 4 Form 4 — Kendrick Charles Morgan JR View Filing
form 4 Form 4 — COLLIS STEVEN H View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
edgar index 4 — Elevance Health, Inc. View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — Haytaian Peter D View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — LAVU RATNAKAR View Filing
form 4 Form 4 — Norwood Felicia F View Filing
form 4 Form 4 — Kaye Mark View Filing
form 4 Form 4 — Kendrick Charles Morgan JR View Filing
form 4 Form 4 — Craig Ryan R View Filing
form 4 Form 4 — Wessling Erin M View Filing
edgar index 8-K — Elevance Health, Inc. View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — BOUDREAUX GAIL View Filing
form 4 Form 4 — Haytaian Peter D View Filing
form 4 Form 4 — Haytaian Peter D View Filing
form 4 Form 4 — Penczek Ronald W View Filing
form 4 Form 4 — Penczek Ronald W View Filing